Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 51 studies | 43% ± 19% | |
fibroblast | 45 studies | 50% ± 20% | |
pericyte | 34 studies | 38% ± 16% | |
smooth muscle cell | 33 studies | 40% ± 18% | |
endothelial cell of lymphatic vessel | 24 studies | 50% ± 17% | |
astrocyte | 22 studies | 77% ± 19% | |
ciliated cell | 17 studies | 46% ± 18% | |
oligodendrocyte precursor cell | 16 studies | 71% ± 20% | |
basal cell | 15 studies | 43% ± 21% | |
connective tissue cell | 15 studies | 43% ± 19% | |
oligodendrocyte | 15 studies | 64% ± 14% | |
myofibroblast cell | 15 studies | 42% ± 18% | |
mesothelial cell | 15 studies | 45% ± 19% | |
macrophage | 14 studies | 38% ± 20% | |
microglial cell | 14 studies | 52% ± 14% | |
capillary endothelial cell | 13 studies | 34% ± 15% | |
endothelial cell of artery | 13 studies | 37% ± 13% | |
vein endothelial cell | 13 studies | 40% ± 18% | |
glutamatergic neuron | 11 studies | 41% ± 17% | |
epithelial cell | 11 studies | 44% ± 24% | |
endothelial cell of vascular tree | 11 studies | 36% ± 16% | |
adipocyte | 11 studies | 71% ± 18% | |
mast cell | 11 studies | 29% ± 11% | |
club cell | 10 studies | 43% ± 22% | |
GABAergic neuron | 10 studies | 40% ± 17% | |
type I pneumocyte | 7 studies | 29% ± 7% | |
secretory cell | 7 studies | 29% ± 10% | |
neuron | 7 studies | 49% ± 27% | |
respiratory goblet cell | 6 studies | 45% ± 24% | |
hepatocyte | 6 studies | 61% ± 24% | |
abnormal cell | 6 studies | 36% ± 19% | |
glial cell | 6 studies | 48% ± 25% | |
interneuron | 6 studies | 49% ± 15% | |
retina horizontal cell | 6 studies | 34% ± 17% | |
cardiac muscle cell | 6 studies | 65% ± 22% | |
Mueller cell | 6 studies | 65% ± 17% | |
type II pneumocyte | 6 studies | 50% ± 9% | |
adventitial cell | 5 studies | 50% ± 12% | |
mucus secreting cell | 5 studies | 47% ± 20% | |
goblet cell | 5 studies | 35% ± 31% | |
duct epithelial cell | 4 studies | 36% ± 29% | |
endothelial cell of sinusoid | 4 studies | 37% ± 17% | |
progenitor cell | 4 studies | 67% ± 28% | |
granule cell | 4 studies | 78% ± 12% | |
erythroblast | 4 studies | 39% ± 9% | |
amacrine cell | 4 studies | 41% ± 33% | |
retinal pigment epithelial cell | 4 studies | 60% ± 15% | |
lymphocyte | 4 studies | 31% ± 11% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 35% ± 10% | |
myeloid cell | 4 studies | 38% ± 11% | |
myoepithelial cell | 4 studies | 46% ± 26% | |
muscle cell | 4 studies | 44% ± 7% | |
monocyte | 4 studies | 26% ± 9% | |
erythrocyte | 4 studies | 43% ± 15% | |
epithelial cell of proximal tubule | 4 studies | 38% ± 13% | |
cholangiocyte | 3 studies | 55% ± 13% | |
hepatic stellate cell | 3 studies | 68% ± 15% | |
T cell | 3 studies | 28% ± 7% | |
glomerular endothelial cell | 3 studies | 29% ± 7% | |
renal alpha-intercalated cell | 3 studies | 25% ± 4% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 63% ± 11% | |
interstitial cell of Cajal | 3 studies | 55% ± 7% | |
neural crest cell | 3 studies | 33% ± 14% | |
GABAergic interneuron | 3 studies | 24% ± 5% | |
serous secreting cell | 3 studies | 31% ± 0% | |
endocardial cell | 3 studies | 71% ± 8% | |
mononuclear phagocyte | 3 studies | 17% ± 1% | |
GABAergic amacrine cell | 3 studies | 19% ± 2% | |
luminal cell of prostate epithelium | 3 studies | 32% ± 18% | |
ependymal cell | 3 studies | 88% ± 5% | |
intestinal crypt stem cell | 3 studies | 26% ± 7% | |
alveolar macrophage | 3 studies | 27% ± 2% | |
chondrocyte | 3 studies | 58% ± 7% | |
Schwann cell | 3 studies | 41% ± 14% | |
transit amplifying cell | 3 studies | 47% ± 31% | |
kidney loop of Henle epithelial cell | 3 studies | 24% ± 4% | |
parietal epithelial cell | 3 studies | 52% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 51% ± 14% | |
lung | 11 studies | 34% ± 11% | |
eye | 8 studies | 27% ± 17% | |
intestine | 7 studies | 26% ± 12% | |
liver | 6 studies | 39% ± 18% | |
heart | 6 studies | 54% ± 17% | |
kidney | 5 studies | 28% ± 9% | |
breast | 4 studies | 32% ± 11% | |
uterus | 3 studies | 37% ± 11% | |
adipose | 3 studies | 66% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5688.58 | 245 / 245 | 100% | 5.26 | 502 / 502 |
thymus | 100% | 6490.25 | 653 / 653 | 99% | 5.97 | 601 / 605 |
brain | 100% | 4784.20 | 2638 / 2642 | 99% | 9.73 | 701 / 705 |
esophagus | 100% | 6599.69 | 1445 / 1445 | 99% | 5.80 | 181 / 183 |
ovary | 100% | 4471.28 | 180 / 180 | 97% | 4.97 | 418 / 430 |
breast | 100% | 5253.86 | 459 / 459 | 94% | 6.83 | 1053 / 1118 |
stomach | 100% | 3394.22 | 358 / 359 | 93% | 3.92 | 265 / 286 |
liver | 98% | 3381.64 | 222 / 226 | 94% | 2.83 | 382 / 406 |
uterus | 100% | 4061.19 | 170 / 170 | 92% | 4.04 | 422 / 459 |
intestine | 100% | 4778.17 | 964 / 966 | 92% | 2.83 | 485 / 527 |
pancreas | 97% | 1611.74 | 318 / 328 | 92% | 2.53 | 164 / 178 |
kidney | 97% | 1893.40 | 86 / 89 | 92% | 4.64 | 826 / 901 |
lung | 99% | 3150.94 | 574 / 578 | 85% | 3.09 | 985 / 1155 |
bladder | 100% | 6222.19 | 21 / 21 | 73% | 2.48 | 369 / 504 |
skin | 99% | 2620.00 | 1788 / 1809 | 65% | 1.91 | 309 / 472 |
adrenal gland | 100% | 4431.69 | 258 / 258 | 59% | 1.08 | 135 / 230 |
adipose | 100% | 5652.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7748.33 | 1335 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3838.44 | 856 / 861 | 0% | 0 | 0 / 0 |
spleen | 99% | 2193.03 | 238 / 241 | 0% | 0 | 0 / 0 |
muscle | 98% | 2303.20 | 787 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 3.00 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 44% | 1.02 | 35 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.08 | 2 / 29 |
peripheral blood | 1% | 7.35 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0048665 | Biological process | neuron fate specification |
GO_0061351 | Biological process | neural precursor cell proliferation |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0006260 | Biological process | DNA replication |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0010458 | Biological process | exit from mitosis |
GO_0060074 | Biological process | synapse maturation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0072189 | Biological process | ureter development |
GO_0035108 | Biological process | limb morphogenesis |
GO_0021780 | Biological process | glial cell fate specification |
GO_0010467 | Biological process | gene expression |
GO_0000902 | Biological process | cell morphogenesis |
GO_0051216 | Biological process | cartilage development |
GO_0009611 | Biological process | response to wounding |
GO_0019079 | Biological process | viral genome replication |
GO_0014009 | Biological process | glial cell proliferation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030054 | Cellular component | cell junction |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
Gene name | NFIA |
Protein name | Nuclear factor I A (Nuclear factor I/A, isoform CRA_c) Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein) Nuclear factor I A (Nuclear factor I/A, isoform CRA_b) Nuclear factor I A CCAAT-box-binding transcription factor (TGGCA-binding protein) Nuclear factor 1 |
Synonyms | KIAA1439 hCG_2032260 |
Description | FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . FUNCTION: Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication. . |
Accessions | A0A8V8TP65 ENST00000485903.6 ENST00000699993.1 ENST00000371191.5 A0A590UJ82 A0A8V8TQI3 A0A8V8TPG7 ENST00000699967.1 ENST00000699968.1 S4R3K5 ENST00000476646.5 ENST00000493627.1 ENST00000662015.1 A0A8V8TPN0 A0A590UJU2 A0A8V8TP49 ENST00000407417.7 [Q12857-3] A0A590UJ67 ENST00000699986.1 S4R3W2 S4R3W6 ENST00000655770.1 ENST00000371189.8 [Q12857-4] ENST00000699964.1 S4R308 A0A8V8TQG7 ENST00000371185.6 ENST00000663597.1 ENST00000403491.8 [Q12857-1] ENST00000699966.1 B1AKN6 ENST00000699987.1 ENST00000496712.1 ENST00000657234.1 ENST00000371184.6 A0A8V8TQV0 ENST00000699965.1 A0A590UK73 A0A590UK09 ENST00000664149.1 A0A590UK38 ENST00000371187.7 [Q12857-2] ENST00000670151.1 ENST00000664495.1 ENST00000357977.5 A0A590UJA3 B1AKN7 S4R3K4 B1AKN5 B1AKN8 Q12857 ENST00000482020.2 |